By Jonathan Kimmelman, associate professor at McGill University and director of its Biomedical Ethics Unit, and Alex John London (Carnegie Mellon) 

There is a lot of money behind providing cancer care, and cancer treatment centers spend an estimated $173 million on advertising each year. One of the ways they compete for patients is by offering a menu of clinical trial options and suggesting that participating in such trials gives patients an edge on their care.

Classified as: bioethics, Clinical trials, mcgill medicine
Category:
Published on: 25 Apr 2018

Antibiotic resistance is a growing global health threat. So much so that a 2014 study commissioned by the Prime Minister of the United Kingdom predicted that, if the problem is left unchecked, in less than 35 years more people will die from antibiotic resistant superbugs than from cancer. It is critical that researchers develop new antibiotics informed by knowledge of how superbugs are resistant to this medication.

Classified as: medicine, McGill, mcgill research, antibiotics, Antibiotic resistance, berguis, mcgill medicine
Category:
Published on: 3 May 2017
Back to top